Publication | Open Access

Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial

ThrombosisPhase 3Ischemic StrokeCardiovascular DiseaseMedicinePatient SafetyMr AsapCerebrovascular DiseasePresumed Acute StrokeBrain InjuryNeurologyCerebrovascular InterventionCerebral Blood FlowPublic HealthStrokeIschemic SyndromeEmergency Medicine